Bcr-Abl Tyrosine Kinase Inhibitors

DBCAT005512Pharmacologic classL01EA

A DrugBank category of 6 drugs. 6 of them are approved.

ATC classification: L — ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 — ANTINEOPLASTIC AGENTS
L01E — PROTEIN KINASE INHIBITORS
L01EA — BCR-ABL tyrosine kinase inhibitors
Drugs: Asciminib
Bosutinib
Dasatinib
Imatinib
Nilotinib
Ponatinib

What you can answer from here — as of July 28, 2021

6DrugsEach linked to its full drug card

Listed above

47Drug targetsEvery drug–target pair in the class, with bond type

1,599Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Bcr-Abl Tyrosine Kinase Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.